← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $168B	2,231	-13	-0.6%	$150B
2	2 Amgen AMGN $235B	1,750	+15	+0.9%	$89.8B
3	3 Eli Lilly LLY $1.12T	1,334	-39	-3%	$64.7B
4	4 Becton Dickinson BDX $52.8B	1,261	+23	+2%	$49.3B
5	5 McKesson MCK $116B	891	-36	-4%	$26B
6	6 Conagra Brands CAG $6.77B	710	-1	-0.1%	$11.5B
7	7 Regeneron Pharmaceuticals REGN $82B	620	-19	-3%	$24.9B
8	8 Novo Nordisk NVO $173B	553	+1	+0.2%	$8.09B
9	9 Lamb Weston LW $7.47B	528	+22	+4%	$6.97B
10	10 AstraZeneca AZN $259B	520	+16	+3%	$13.9B
11	11 Teva Pharmaceutical Industries Limited TEVA $47.9B	507	-1	-0.2%	$11.5B
12	12 DaVita DVA $12.1B	498	+19	+4%	$10.3B
13	13 ResMed RMD $34.1B	446	+30	+7%	$8.89B
14	14 West Pharmaceutical WST $27B	323	-15	-4%	$6.2B
15	15 DELISTED CATALENT, INC. CTLT	274	-2	-0.7%	$5.55B
16	16 Accendra Health ACH $20.1M	242	+12	+5%	$892M
17	17 Fresenius Medical Care FMS $11.8B	233	+13	+6%	$781M
18	18 Opko Health OPK $1.2B	227	-5	-2%	$437M
19	19 Medifast MED $135M	225	+24	+12%	$1,000M
20	20 DELISTED WW International WW	224	+30	+15%	$3.84B
21	21 Herbalife HLF $1.53B	206	+2	+1%	$7.79B
22	22 Tootsie Roll Industries TR $2.88B	176	-2	-1%	$411M
23	ARNA 23 DELISTED Arena Pharmaceuticals Inc ARNA	170	+45	+36%	$1.53B
24	TWNK 24 DELISTED Hostess Brands, Inc. Class A Common Stock TWNK	149	-9	-6%	$1.64B
25	25 Alaunos Therapeutics TCRT $5.54M	133	+5	+4%	$228M